Journals / ANKEM Dergisi / 2008 / Cilt: 22 - Sayı: 4

The frequency of extended-spectrum beta-lactamases (EBSL) in Escherichia coli and Klebsiella pneumoniae strains isolated from blood cultures

Kan kültürlerinden izole edilen Escherichia coli ve Klebsiella pneumoniae suşlarında genişlemiş spektrumlu beta-laktamaz (GSBL) sıklığı

Pages
175–182
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Studies are needed to decrease the incidence of these bacteria.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Between January 2007 and January 2008, 20 out of the 59 E.coli (34 %), and 10 out of the 40 K.pneumoniae strains (24 %) isolated from blood samples sent from different clinics, were found to be ESBL producers.
📊
Key Findings & Data:The most effective antibiotics against ESBL producing E.coli and K.pneumoniae were imipenem (100 % and 100 %), cefoperazone+sulbactam (90 % and 70 %) and piperacilin+tazobactam (65 % and 50 %), respectively.
💡
Conclusion & Impact:Studies are needed to decrease the incidence of these bacteria.
🔬Design:Research Article
📍Scope:2007 Verileri
⚙️Variables:beta-Laktamazlar · Kültür ortamı · Escherichia coli

Abstract

Between January 2007 and January 2008, 20 out of the 59 E.coli (34 %), and 10 out of the 40 K.pneumoniae strains (24 %) isolated from blood samples sent from different clinics, were found to be ESBL producers. The most effective antibiotics against ESBL producing E.coli and K.pneumoniae were imipenem (100 % and 100 %), cefoperazone+sulbactam (90 % and 70 %) and piperacilin+tazobactam (65 % and 50 %), respectively. Incidence of the ESBL producing bacteria were found to be 53 % in surgical ward and 20 % in internal emergency unit. These findings prove that incidence of ESBL producing E.coli and K.pneumoniae strains isolated from blood samples is high at our hospital. Studies are needed to decrease the incidence of these bacteria.

Özet

28 Ocak 2007-6 Ocak 2008 arasında, Cerrahpaşa Tıp Fakültesi’nin çeşitli kliniklerinden gönderilen kan kültürlerinden üretilen 59 Escherichia coli suşunun 20’sinin (% 34), 41 Klebsiella pneumoniae suşunun 10’unun (% 24), GSBL oluşturduğu saptanmıştır. GSBL üreten E.coli ve K.pneumoniae suşlarına in-vitro en etkili antibiyotikler olarak sırasıyla imipemen (% 100 ve % 100), sefoperazon+sulbaktam (% 90 ve % 70) ve piperasilin+tazobaktam (% 65 ve % 50) bulunmuştur. GSBL üreten suş sıkılığı genel cerrahi servisinde yatan hastalarda % 53, acil dahiliye servisinde yatan hastalarda % 20 olarak bulunmuştur. Bu bulgular hastanemizde kan kültürlerinden izole edilen E.coli ve K.pneumoniae suşlarında GSBL oranlarının yüksek olduğunu göstermektedir. Bu oranların düşürülmesi için çalışmaların başlatılması gereği ortaya çıkmıştır.

🔖

Cite This Article

AL-MUHTASEB, M., KAYGUSUZ, A. (2008). The frequency of extended-spectrum beta-lactamases (EBSL) in Escherichia coli and Klebsiella pneumoniae strains isolated from blood cultures. ANKEM Dergisi, Cilt: 22 - Sayı: 4, 175–182. https://ajindex.com/articles/193174

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (13)

  1. Barry AL, Jones RN: Criteria for disk susceptibility tests and quality control guidelines for the cefoperazone-sulbactam combination, J Clin Microbiol 1988;26(1):13-7
  2. Bradford PA: Extended-spectrum b-lactamases in the 21st century: characterization, epidemiology, and detection of this important resistance threat, Clin Microbiol Rev 2001;14(4):933-51
  3. Bradford PA, Sanders CC: Use of a predictor panel for development of a new disk for diffusion tests with cefoperazone-sulbactam, Antimicrob Agents Chemother 1992;36(6):394-400
  4. Bush K: Extended-spectrum beta-lactamases in North America, 1987-2006, Clin Microbiol Infect 2008;14(Suppl 1):134-43
  5. Cantón R, Morosini MI, de la Maza OM, de la Pedrosa EG: IRT and CMT beta-lactamases and inhibitor resistance, Clin Microbiol Infect 2008;14(Suppl 1):53-62
  6. Cantón R, Novais A, Valverde A et al: Prevalence and spread of extended-spectrum beta-lactamaseproducing Enterobacteriaceae in Europe, Clin Microbiol Infect 2008;14(Suppl 1):144-53
  7. Chaibi E, Sirot D, Paul G, Labia R: Inhibitor resistant TEM beta-lactamases: Phenotypic, genetic and biochemical characteristics, J Antimicrob Chemother 1999;43(4):447-58
  8. Clinical and Laboratory Standards Institute (Çeviri editörü D Gür): Antibiyotik Duyarlılık Testleri İçin Uygulama Standartları
  9. Bilgi Eki, Bilimsel Tıp Yayınevi, Ankara (2008)
  10. Cornaglia G, Garau J, Livermore DM: Living with ESBLs, Clin Microbiol Infect 2008;14(Suppl 1):1-2
  11. Çolakoğlu Ş, Turunç T, Alışkan H, Demiroğlu YZ, Timurkaynak F, Arslan H: Kan kültürlerinden izole edilen Escherichia coli ve Klebsiella pneumoniae suşlarında antibiyotik duyarlılığı, “Gür D (ed): 8. Antimikrobik Kemoterapi Günleri” Program ve Özet Kitabı s. 220-1, Türk Mikrobiyol Cem yayını No: 57, İstanbul (2008)
  12. Demirözü Z: Kan kültürlerinden izole edilen K.pneumoniae, K.oxytoca ve E.coli izolatlarında genişlemiş spektrumlu beta-laktamaz enzimi varlığının araştırılması, Yüksek Lisans Tezi, Gazi Üniversitesi Fen Bilimleri Enstitüsü, Ankara (2007). http://www.acikarsiv.gazi.edu.tr/dosya/ zerrin_demirozu_tez.pdf 12. Drieux L, Brossier F, Sougakoff W, Jarlier V: Phenotypic detection of extended-spectrum betalactamase production in Enterobacteriaceae: review and bench guide, Clin Microbiol Infect 2008;14(Suppl 1):90-103
  13. European Committee on Antimicrobial Susceptibility Testing (EUCAST): Expert rules in antimicrobial susceptibility testing (2008). http:// www.srga.org/eucastwt/EUCAST%20Expert%20 rules%20fina